• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TRI

TRIVARX LTD - Announcements

0.00% ! 1.1¢
Market Cap $6.818M  !

TrivarX Limited, formerly Medibio Limited, is an Australia-based mental health technology... TrivarX Limited, formerly Medibio Limited, is an Australia-based mental health technology company engaged in the use of objective measures to aid in the early detection and screening of mental health conditions. Through the Company’s corporate health product, it offers mental well-being solutions for businesses and is also developing products to serve the healthcare provider market. The principal activity of the Company is development of artificial intelligence (AI)-driven, scientifically based devices for screening and diagnosis of behavioral health conditions. Its clinical research has enabled the development of proprietary algorithms for spectral analyses of sleep architecture and heart-rate variability. The Company’s lead product, MEB-001 analyses the data from a standard sleep study to identify depression at a sensitivity of over 85%. Its technology analyses the electrical signals from the brain and the heart to identify mental illness.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements



TRI Investor Presentation28/11/18 download Created with Sketch. 3.44MB
TRI Exclusive Agreement Signed for ilumen Pilot ProgramPRICE SENSITIVE27/11/18 download Created with Sketch. 225.94KB
TRI Appointment of Joint Company Secretary16/11/18 download Created with Sketch. 204.97KB
TRI Results of Annual General Meeting16/11/18 download Created with Sketch. 121.66KB
TRI Chairman's Address to Shareholders16/11/18 download Created with Sketch. 114.91KB
TRI Response to ASX Appendix 4C QueryPRICE SENSITIVE15/11/18 download Created with Sketch. 548.31KB
TRI Change of Director's Interest Notice14/11/18 download Created with Sketch. 257.64KB
TRI Medibio Provides Update on FDA ProcessPRICE SENSITIVE09/11/18 download Created with Sketch. 194.76KB
TRI Change of Director's Interest Notice x208/11/18 download Created with Sketch. 359.73KB
TRI Initial Director's Interest Notice08/11/18 download Created with Sketch. 177.34KB
TRI Medibio Appoints CEO and Managing DirectorPRICE SENSITIVE02/11/18 download Created with Sketch. 216.44KB
TRI Medibio Market UpdatePRICE SENSITIVE02/11/18 download Created with Sketch. 175.45KB
TRI Medibio Quarterly Update and Cashflow ReportPRICE SENSITIVE30/10/18 download Created with Sketch. 353.35KB
TRI MEB Signs ilumen Contract with Large Australian EmployerPRICE SENSITIVE24/10/18 download Created with Sketch. 207.34KB
TRI Notice of Annual General Meeting/Proxy Form16/10/18 download Created with Sketch. 5.76MB
TRI Receipt of R&D Tax Incentive RefundPRICE SENSITIVE15/10/18 download Created with Sketch. 96.66KB
TRI MEB Presentations - Mayo Clinic Convergence Neuroscience08/10/18 download Created with Sketch. 99.54KB
TRI Investor Presentation05/10/18 download Created with Sketch. 10.87MB
TRI Medibio Releases Corporate Health Product, ilumenPRICE SENSITIVE03/10/18 download Created with Sketch. 172.87KB
TRI Notice of Initial Substantial Holder02/10/18 download Created with Sketch. 1.62MB
TRI Notice Received Under Section 249D of the Corporations ActPRICE SENSITIVE01/10/18 download Created with Sketch. 89.25KB
TRI Annual Report to shareholders27/09/18 download Created with Sketch. 5.71MB
TRI Final Director's Interest Notice21/09/18 download Created with Sketch. 194.57KB
TRI Executive Leadership ChangesPRICE SENSITIVE21/09/18 download Created with Sketch. 107.16KB
TRI Appendix 4G & Corporate Governance Statement14/09/18 download Created with Sketch. 432.6KB
TRI Annual Report to shareholders14/09/18 download Created with Sketch. 1.74MB
TRI Medibio Market Update10/09/18 download Created with Sketch. 212.6KB
TRI Medibio Hosts Call to Discuss Clinical Validation Study07/09/18 download Created with Sketch. 172.64KB
TRI Clinical Study Shows Improvement to Diagnostic StandardPRICE SENSITIVE06/09/18 download Created with Sketch. 279.44KB
TRI Preliminary Final ReportPRICE SENSITIVE30/08/18 download Created with Sketch. 797.56KB
TRI Departure of Managing Director & Chief Executive OfficerPRICE SENSITIVE29/08/18 download Created with Sketch. 213.68KB
TRI Trading HaltPRICE SENSITIVE28/08/18 download Created with Sketch. 344.14KB
TRI Pause in TradingPRICE SENSITIVE28/08/18 download Created with Sketch. 116.44KB
TRI Medibio Quarterly Update and Cashflow ReportPRICE SENSITIVE31/07/18 download Created with Sketch. 309.35KB
TRI MEB to announce fourth quarter FY18 results (Updated)31/07/18 download Created with Sketch. 128.54KB
TRI MEB to announce fourth quarter FY18 results30/07/18 download Created with Sketch. 128.37KB
TRI Medibio Submits FDA De Novo ApplicationPRICE SENSITIVE16/07/18 download Created with Sketch. 104.57KB
TRI Medibio Science published in EC Neurology27/06/18 download Created with Sketch. 171.12KB
TRI Change of Director's Interest Notices x621/06/18 download Created with Sketch. 287.95KB
TRI Appendix 3B21/06/18 download Created with Sketch. 239.54KB
TRI Medibio Receives TGA ApprovalPRICE SENSITIVE19/06/18 download Created with Sketch. 131.54KB
TRI Medibio to provide Corporate Health Investor Presentation18/06/18 download Created with Sketch. 8.04MB
TRI Medibio provides updated Investor Presentation12/06/18 download Created with Sketch. 13.77MB
TRI Company Secretary Appointment/Resignation06/06/18 download Created with Sketch. 93.07KB
TRI Results of Meeting06/06/18 download Created with Sketch. 249.63KB
TRI MEB Signs Global Contract with Jacobs EngineeringPRICE SENSITIVE25/05/18 download Created with Sketch. 203.19KB
TRI Medibio Announces Next Tranche of Corporate Health ContractsPRICE SENSITIVE10/05/18 download Created with Sketch. 152.6KB
TRI Medibio Signs First Corporate Health ContractPRICE SENSITIVE09/05/18 download Created with Sketch. 154.51KB
TRI Notice of Extraordinary General Meeting/Proxy Form07/05/18 download Created with Sketch. 496.74KB
TRI Medibio Receives CE CertificationPRICE SENSITIVE03/05/18 download Created with Sketch. 146.93KB
TRI Medibio Announces Global Corporate Mental Health Launch01/05/18 download Created with Sketch. 182.01KB
TRI Medibio Quarterly Update and Cashflow ReportPRICE SENSITIVE30/04/18 download Created with Sketch. 607.55KB
TRI MEB to announce third quarter FY18 update and cashflow27/04/18 download Created with Sketch. 218.53KB
TRI Medibio Announces Scientific Advisory Board26/04/18 download Created with Sketch. 135.81KB
TRI Appendix 3B & S708 cleansing notice17/04/18 download Created with Sketch. 211.93KB
TRI Medibio completes Vital Conversation acquisition12/04/18 download Created with Sketch. 198.93KB
TRI Change in substantial holding11/04/18 download Created with Sketch. 195.56KB
TRI Appendix 3B and S708 cleansing statement05/03/18 download Created with Sketch. 205.1KB
TRI MEB signs binding term sheet to acquire Vital ConversationsPRICE SENSITIVE05/03/18 download Created with Sketch. 174.72KB
TRI Investor Update05/03/18 download Created with Sketch. 6.99MB
TRI Half Yearly Report and AccountsPRICE SENSITIVE27/02/18 download Created with Sketch. 868.21KB
TRI Medibio Quarterly Update and Cash Flow ReportPRICE SENSITIVE31/01/18 download Created with Sketch. 197.91KB
TRI MEB to announce second quarter FY18 update and cashflow30/01/18 download Created with Sketch. 132.54KB
TRI Final Director's Interest Notice22/01/18 download Created with Sketch. 84.56KB
TRI Agreement with Striiv to Accelerate CommercialisationPRICE SENSITIVE22/01/18 download Created with Sketch. 121.89KB
TRI Peter Carlisle Appointed as Director22/01/18 download Created with Sketch. 135.07KB
TRI Resignation of Director19/01/18 download Created with Sketch. 76.42KB
TRI Appendix 3B16/01/18 download Created with Sketch. 163.43KB
TRI Medibio Announces ISO 13485 CertificationPRICE SENSITIVE10/01/18 download Created with Sketch. 174.59KB
TRI Medibio & Mayo Clinic collaborate on depression technologyPRICE SENSITIVE14/12/17 download Created with Sketch. 553.3KB
TRI US Veterans Affairs joins Medibio FDA study08/12/17 download Created with Sketch. 101.23KB
TRI Appendix 3B05/12/17 download Created with Sketch. 165.99KB
TRI Results of Meeting30/11/17 download Created with Sketch. 62.33KB
TRI Chairman's & CEO Address to Shareholders30/11/17 download Created with Sketch. 1.19MB
TRI Appendix 3B14/11/17 download Created with Sketch. 162.69KB
TRI Appendix 4G & Corporate Governance Statement13/11/17 download Created with Sketch. 328.85KB
TRI Notice of Annual General Meeting/Proxy Form01/11/17 download Created with Sketch. 1.11MB
TRI Appendix 4C - quarterlyPRICE SENSITIVE30/10/17 download Created with Sketch. 474.28KB
TRI R&D Tax Incentive Refund received25/10/17 download Created with Sketch. 96.95KB
TRI Becoming a substantial holder24/10/17 download Created with Sketch. 102.12KB
TRI Annual Report to shareholders24/10/17 download Created with Sketch. 5.22MB
TRI Disclosure Document - Cleansing Statement23/10/17 download Created with Sketch. 54.13KB
TRI Appendix 3B23/10/17 download Created with Sketch. 164.12KB
TRI Final Director's Interest Notice13/10/17 download Created with Sketch. 89.07KB
TRI Change of Director's Interest Notice13/10/17 download Created with Sketch. 104.61KB
TRI Director Resignation13/10/17 download Created with Sketch. 80.74KB
TRI MEB completes heavily oversubscribed institutional placementPRICE SENSITIVE13/10/17 download Created with Sketch. 576.71KB
TRI Appendix 3B12/10/17 download Created with Sketch. 163.92KB
TRI Trading HaltPRICE SENSITIVE11/10/17 download Created with Sketch. 288.12KB
TRI Response to ASX QueryPRICE SENSITIVE11/10/17 download Created with Sketch. 429.87KB
TRI Medibio enters into an Agreement with Otsuka PharmaceuticalPRICE SENSITIVE09/10/17 download Created with Sketch. 585.28KB
TRI Change of Directors Interest Notice04/10/17 download Created with Sketch. 120.33KB
TRI Medibio enters agreement with Mayo ClincPRICE SENSITIVE04/10/17 download Created with Sketch. 676.15KB
TRI Full Year Statutory Accounts29/09/17 download Created with Sketch. 10.8MB
TRI Appendix 3B29/09/17 download Created with Sketch. 161.25KB
TRI Results of Meeting11/09/17 download Created with Sketch. 206.52KB
TRI Medibio Investment Presentation Update11/09/17 download Created with Sketch. 6.16MB
TRI Preliminary Final ReportPRICE SENSITIVE01/09/17 download Created with Sketch. 464.55KB
TRI Change of Director's Interest Notice31/08/17 download Created with Sketch. 127.54KB
TRI Appendix 3B29/08/17 download Created with Sketch. 159.79KB
TRI Investor Presentation
28/11/18 download Created with Sketch. 3.44MB
TRI Exclusive Agreement Signed for ilumen Pilot Program
27/11/18PRICE SENSITIVE download Created with Sketch. 225.94KB
TRI Appointment of Joint Company Secretary
16/11/18 download Created with Sketch. 204.97KB
TRI Results of Annual General Meeting
16/11/18 download Created with Sketch. 121.66KB
TRI Chairman's Address to Shareholders
16/11/18 download Created with Sketch. 114.91KB
TRI Response to ASX Appendix 4C Query
15/11/18PRICE SENSITIVE download Created with Sketch. 548.31KB
TRI Change of Director's Interest Notice
14/11/18 download Created with Sketch. 257.64KB
TRI Medibio Provides Update on FDA Process
09/11/18PRICE SENSITIVE download Created with Sketch. 194.76KB
TRI Change of Director's Interest Notice x2
08/11/18 download Created with Sketch. 359.73KB
TRI Initial Director's Interest Notice
08/11/18 download Created with Sketch. 177.34KB
TRI Medibio Appoints CEO and Managing Director
02/11/18PRICE SENSITIVE download Created with Sketch. 216.44KB
TRI Medibio Market Update
02/11/18PRICE SENSITIVE download Created with Sketch. 175.45KB
TRI Medibio Quarterly Update and Cashflow Report
30/10/18PRICE SENSITIVE download Created with Sketch. 353.35KB
TRI MEB Signs ilumen Contract with Large Australian Employer
24/10/18PRICE SENSITIVE download Created with Sketch. 207.34KB
TRI Notice of Annual General Meeting/Proxy Form
16/10/18 download Created with Sketch. 5.76MB
TRI Receipt of R&D Tax Incentive Refund
15/10/18PRICE SENSITIVE download Created with Sketch. 96.66KB
TRI MEB Presentations - Mayo Clinic Convergence Neuroscience
08/10/18 download Created with Sketch. 99.54KB
TRI Investor Presentation
05/10/18 download Created with Sketch. 10.87MB
TRI Medibio Releases Corporate Health Product, ilumen
03/10/18PRICE SENSITIVE download Created with Sketch. 172.87KB
TRI Notice of Initial Substantial Holder
02/10/18 download Created with Sketch. 1.62MB
TRI Notice Received Under Section 249D of the Corporations Act
01/10/18PRICE SENSITIVE download Created with Sketch. 89.25KB
TRI Annual Report to shareholders
27/09/18 download Created with Sketch. 5.71MB
TRI Final Director's Interest Notice
21/09/18 download Created with Sketch. 194.57KB
TRI Executive Leadership Changes
21/09/18PRICE SENSITIVE download Created with Sketch. 107.16KB
TRI Appendix 4G & Corporate Governance Statement
14/09/18 download Created with Sketch. 432.6KB
TRI Annual Report to shareholders
14/09/18 download Created with Sketch. 1.74MB
TRI Medibio Market Update
10/09/18 download Created with Sketch. 212.6KB
TRI Medibio Hosts Call to Discuss Clinical Validation Study
07/09/18 download Created with Sketch. 172.64KB
TRI Clinical Study Shows Improvement to Diagnostic Standard
06/09/18PRICE SENSITIVE download Created with Sketch. 279.44KB
TRI Preliminary Final Report
30/08/18PRICE SENSITIVE download Created with Sketch. 797.56KB
TRI Departure of Managing Director & Chief Executive Officer
29/08/18PRICE SENSITIVE download Created with Sketch. 213.68KB
TRI Trading Halt
28/08/18PRICE SENSITIVE download Created with Sketch. 344.14KB
TRI Pause in Trading
28/08/18PRICE SENSITIVE download Created with Sketch. 116.44KB
TRI Medibio Quarterly Update and Cashflow Report
31/07/18PRICE SENSITIVE download Created with Sketch. 309.35KB
TRI MEB to announce fourth quarter FY18 results (Updated)
31/07/18 download Created with Sketch. 128.54KB
TRI MEB to announce fourth quarter FY18 results
30/07/18 download Created with Sketch. 128.37KB
TRI Medibio Submits FDA De Novo Application
16/07/18PRICE SENSITIVE download Created with Sketch. 104.57KB
TRI Medibio Science published in EC Neurology
27/06/18 download Created with Sketch. 171.12KB
TRI Change of Director's Interest Notices x6
21/06/18 download Created with Sketch. 287.95KB
TRI Appendix 3B
21/06/18 download Created with Sketch. 239.54KB
TRI Medibio Receives TGA Approval
19/06/18PRICE SENSITIVE download Created with Sketch. 131.54KB
TRI Medibio to provide Corporate Health Investor Presentation
18/06/18 download Created with Sketch. 8.04MB
TRI Medibio provides updated Investor Presentation
12/06/18 download Created with Sketch. 13.77MB
TRI Company Secretary Appointment/Resignation
06/06/18 download Created with Sketch. 93.07KB
TRI Results of Meeting
06/06/18 download Created with Sketch. 249.63KB
TRI MEB Signs Global Contract with Jacobs Engineering
25/05/18PRICE SENSITIVE download Created with Sketch. 203.19KB
TRI Medibio Announces Next Tranche of Corporate Health Contracts
10/05/18PRICE SENSITIVE download Created with Sketch. 152.6KB
TRI Medibio Signs First Corporate Health Contract
09/05/18PRICE SENSITIVE download Created with Sketch. 154.51KB
TRI Notice of Extraordinary General Meeting/Proxy Form
07/05/18 download Created with Sketch. 496.74KB
TRI Medibio Receives CE Certification
03/05/18PRICE SENSITIVE download Created with Sketch. 146.93KB
TRI Medibio Announces Global Corporate Mental Health Launch
01/05/18 download Created with Sketch. 182.01KB
TRI Medibio Quarterly Update and Cashflow Report
30/04/18PRICE SENSITIVE download Created with Sketch. 607.55KB
TRI MEB to announce third quarter FY18 update and cashflow
27/04/18 download Created with Sketch. 218.53KB
TRI Medibio Announces Scientific Advisory Board
26/04/18 download Created with Sketch. 135.81KB
TRI Appendix 3B & S708 cleansing notice
17/04/18 download Created with Sketch. 211.93KB
TRI Medibio completes Vital Conversation acquisition
12/04/18 download Created with Sketch. 198.93KB
TRI Change in substantial holding
11/04/18 download Created with Sketch. 195.56KB
TRI Appendix 3B and S708 cleansing statement
05/03/18 download Created with Sketch. 205.1KB
TRI MEB signs binding term sheet to acquire Vital Conversations
05/03/18PRICE SENSITIVE download Created with Sketch. 174.72KB
TRI Investor Update
05/03/18 download Created with Sketch. 6.99MB
TRI Half Yearly Report and Accounts
27/02/18PRICE SENSITIVE download Created with Sketch. 868.21KB
TRI Medibio Quarterly Update and Cash Flow Report
31/01/18PRICE SENSITIVE download Created with Sketch. 197.91KB
TRI MEB to announce second quarter FY18 update and cashflow
30/01/18 download Created with Sketch. 132.54KB
TRI Final Director's Interest Notice
22/01/18 download Created with Sketch. 84.56KB
TRI Agreement with Striiv to Accelerate Commercialisation
22/01/18PRICE SENSITIVE download Created with Sketch. 121.89KB
TRI Peter Carlisle Appointed as Director
22/01/18 download Created with Sketch. 135.07KB
TRI Resignation of Director
19/01/18 download Created with Sketch. 76.42KB
TRI Appendix 3B
16/01/18 download Created with Sketch. 163.43KB
TRI Medibio Announces ISO 13485 Certification
10/01/18PRICE SENSITIVE download Created with Sketch. 174.59KB
TRI Medibio & Mayo Clinic collaborate on depression technology
14/12/17PRICE SENSITIVE download Created with Sketch. 553.3KB
TRI US Veterans Affairs joins Medibio FDA study
08/12/17 download Created with Sketch. 101.23KB
TRI Appendix 3B
05/12/17 download Created with Sketch. 165.99KB
TRI Results of Meeting
30/11/17 download Created with Sketch. 62.33KB
TRI Chairman's & CEO Address to Shareholders
30/11/17 download Created with Sketch. 1.19MB
TRI Appendix 3B
14/11/17 download Created with Sketch. 162.69KB
TRI Appendix 4G & Corporate Governance Statement
13/11/17 download Created with Sketch. 328.85KB
TRI Notice of Annual General Meeting/Proxy Form
01/11/17 download Created with Sketch. 1.11MB
TRI Appendix 4C - quarterly
30/10/17PRICE SENSITIVE download Created with Sketch. 474.28KB
TRI R&D Tax Incentive Refund received
25/10/17 download Created with Sketch. 96.95KB
TRI Becoming a substantial holder
24/10/17 download Created with Sketch. 102.12KB
TRI Annual Report to shareholders
24/10/17 download Created with Sketch. 5.22MB
TRI Disclosure Document - Cleansing Statement
23/10/17 download Created with Sketch. 54.13KB
TRI Appendix 3B
23/10/17 download Created with Sketch. 164.12KB
TRI Final Director's Interest Notice
13/10/17 download Created with Sketch. 89.07KB
TRI Change of Director's Interest Notice
13/10/17 download Created with Sketch. 104.61KB
TRI Director Resignation
13/10/17 download Created with Sketch. 80.74KB
TRI MEB completes heavily oversubscribed institutional placement
13/10/17PRICE SENSITIVE download Created with Sketch. 576.71KB
TRI Appendix 3B
12/10/17 download Created with Sketch. 163.92KB
TRI Trading Halt
11/10/17PRICE SENSITIVE download Created with Sketch. 288.12KB
TRI Response to ASX Query
11/10/17PRICE SENSITIVE download Created with Sketch. 429.87KB
TRI Medibio enters into an Agreement with Otsuka Pharmaceutical
09/10/17PRICE SENSITIVE download Created with Sketch. 585.28KB
TRI Change of Directors Interest Notice
04/10/17 download Created with Sketch. 120.33KB
TRI Medibio enters agreement with Mayo Clinc
04/10/17PRICE SENSITIVE download Created with Sketch. 676.15KB
TRI Full Year Statutory Accounts
29/09/17 download Created with Sketch. 10.8MB
TRI Appendix 3B
29/09/17 download Created with Sketch. 161.25KB
TRI Results of Meeting
11/09/17 download Created with Sketch. 206.52KB
TRI Medibio Investment Presentation Update
11/09/17 download Created with Sketch. 6.16MB
TRI Preliminary Final Report
01/09/17PRICE SENSITIVE download Created with Sketch. 464.55KB
TRI Change of Director's Interest Notice
31/08/17 download Created with Sketch. 127.54KB
TRI Appendix 3B
29/08/17 download Created with Sketch. 159.79KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.1¢
Change
0.000(0.00%)
Mkt cap ! $6.818M
Open High Low Value Volume
1.2¢ 1.2¢ 1.1¢ $7.732K 701.4K

Buyers (Bids)

No. Vol. Price($)
7 3030000 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.2¢ 760913 2
View Market Depth
Last trade - 13.06pm 16/09/2025 (20 minute delay) ?
TRI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.